Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Zoetis Operating Margin 2011-2021 | ZTS

For a detailed definition, formula and example for Operating Margin, check out our new background page here.
Current and historical operating margin for Zoetis (ZTS) over the last 10 years. The current operating profit margin for Zoetis as of June 30, 2021 is 28.75%.
  
Zoetis Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2021-06-30 $7.41B $2.34B 31.57%
2021-03-31 $7.01B $2.19B 31.18%
2020-12-31 $6.68B $2.00B 29.90%
2020-09-30 $6.54B $2.01B 30.77%
2020-06-30 $6.34B $1.94B 30.66%
2020-03-31 $6.34B $1.92B 30.24%
2019-12-31 $6.26B $1.80B 28.77%
2019-09-30 $6.15B $1.78B 28.98%
2019-06-30 $6.05B $1.67B 27.65%
2019-03-31 $5.91B $1.65B 27.97%
2018-12-31 $5.83B $1.69B 29.01%
2018-09-30 $5.72B $1.70B 29.75%
2018-06-30 $5.59B $1.70B 30.37%
2018-03-31 $5.44B $1.61B 29.49%
2017-12-31 $5.31B $1.53B 28.74%
2017-09-30 $5.12B $1.33B 25.88%
2017-06-30 $5.02B $1.25B 24.83%
2017-03-31 $4.96B $1.23B 24.87%
2016-12-31 $4.89B $1.23B 25.12%
2016-09-30 $4.89B $1.07B 21.82%
2016-06-30 $4.86B $1.01B 20.71%
2016-03-31 $4.83B $0.65B 13.41%
2015-12-31 $4.77B $0.55B 11.44%
2015-09-30 $4.81B $0.63B 13.12%
2015-06-30 $4.81B $0.60B 12.40%
2015-03-31 $4.79B $0.82B 17.18%
2014-12-31 $4.79B $0.82B 17.14%
2014-09-30 $4.72B $0.79B 16.76%
2014-06-30 $4.61B $0.74B 16.00%
2014-03-31 $4.57B $0.73B 15.87%
2013-12-31 $4.56B $0.69B 15.13%
2013-09-30 $4.48B $0.65B 14.41%
2013-06-30 $4.40B $0.67B 15.32%
2013-03-31 $4.38B $0.74B 16.88%
2012-12-31 $4.34B $0.72B 16.56%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $94.073B $6.675B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $54.271B 8.79
Astellas Pharma (ALPMY) Japan $31.799B 25.12
Merck (MKGAF) Germany $29.725B 23.14
Catalent (CTLT) United States $23.253B 49.15
Eisai (ESALY) Japan $23.025B 40.02
UCB SA (UCBJF) Belgium $20.036B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.759B 26.15
Ono Pharmaceutical (OPHLF) Japan $11.568B 15.31
Grifols, S.A (GRFS) Spain $10.443B 12.72
Neurocrine Biosciences (NBIX) United States $9.124B 25.94
United Therapeutics (UTHR) United States $8.988B 19.44
Evotec AG (EVTCY) Germany $8.672B 64.06
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.299B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.175B 9.43
IPSEN SA ADR (IPSEY) France $8.019B 0.00
STADA ARZNEIMI (STDAF) Germany $6.870B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.770B 0.00
Orion OYJ (ORINY) Finland $6.012B 25.98
Tilray (TLRY) United States $5.445B 0.00
Ionis Pharmaceuticals (IONS) United States $5.252B 0.00
Recursion Pharmaceuticals (RXRX) United States $4.517B 0.00
Hypermarcas (HYPMY) Brazil $3.972B 15.68
Turning Point Therapeutics (TPTX) United States $3.857B 0.00
Relay Therapeutics (RLAY) United States $3.438B 0.00
Nektar Therapeutics (NKTR) United States $3.035B 0.00
PTC Therapeutics (PTCT) United States $3.010B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.808B 0.00
Sage Therapeutics (SAGE) United States $2.729B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.696B 0.00
Pacira BioSciences (PCRX) United States $2.487B 27.56
Taro Pharmaceutical Industries (TARO) Israel $2.459B 16.45
Corcept Therapeutics (CORT) United States $2.378B 26.99
Revolution Medicines (RVMD) United States $2.298B 0.00
Cronos Group (CRON) Canada $2.230B 0.00
Organogenesis Holdings (ORGO) United States $2.142B 29.75
Indivior (INVVY) United States $2.067B 22.54
Xencor (XNCR) United States $2.016B 93.43
Ironwood Pharmaceuticals (IRWD) United States $2.012B 10.56
Trillium Therapeutics (TRIL) Canada $1.817B 0.00
USANA Health Sciences (USNA) United States $1.779B 13.41
AlloVir (ALVR) United States $1.562B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.522B 7.65
Vectura Group (VEGPF) United Kingdom $1.378B 0.00
Heron Therapeutics (HRTX) United States $1.233B 0.00
Sundial Growers (SNDL) Canada $1.204B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.181B 0.00
ImmunoGen (IMGN) United States $1.174B 0.00
ChemoCentryx (CCXI) United States $1.158B 0.00
Aclaris Therapeutics (ACRS) United States $1.112B 0.00
FibroGen (FGEN) United States $1.083B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.059B 0.00
VAXART, INC (VXRT) United States $1.054B 0.00
4D Molecular Therapeutics (FDMT) $0.939B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.879B 0.00
Zogenix (ZGNX) United States $0.848B 0.00
Ocular Therapeutix (OCUL) United States $0.808B 0.00
Bioventus (BVS) United States $0.789B 0.00
Collegium Pharmaceutical (COLL) United States $0.705B 16.52
Rigel Pharmaceuticals (RIGL) United States $0.666B 0.00
Endo (ENDP) Ireland $0.661B 1.07
Rafael Holdings (RFL) United States $0.653B 0.00
Silence Therapeutics (SLN) United Kingdom $0.648B 0.00
Summit Therapeutics (SMMT) United States $0.621B 0.00
Innate Pharma SA (IPHYF) France $0.619B 0.00
Aerie Pharmaceuticals (AERI) United States $0.611B 0.00
Altimmune (ALT) United States $0.605B 0.00
Radius Health (RDUS) United States $0.605B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.604B 0.00
Inotiv (NOTV) United States $0.558B 0.00
Chinook Therapeutics (KDNY) United States $0.556B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.522B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.520B 11.22
Siga Technologies (SIGA) United States $0.508B 12.31
Akebia Therapeutics (AKBA) United States $0.506B 0.00
Foghorn Therapeutics (FHTX) United States $0.489B 0.00
KalVista Pharmaceuticals (KALV) United States $0.470B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.468B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.466B 0.00
AVITA Medical (RCEL) United States $0.464B 0.00
Karyopharm Therapeutics (KPTI) United States $0.458B 0.00
Nanobiotix S.A (NBTX) France $0.443B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.443B 0.00
Jounce Therapeutics (JNCE) United States $0.399B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.399B 0.00
Esperion Therapeutics (ESPR) United States $0.353B 0.00
Acutus Medical (AFIB) United States $0.347B 0.00
Molecular Templates (MTEM) United States $0.336B 0.00
Viracta Therapeutics (VIRX) United States $0.324B 0.00
Infinity Pharmaceuticals (INFI) United States $0.322B 0.00
KemPharm (KMPH) United States $0.319B 0.00
Flexion Therapeutics (FLXN) United States $0.313B 0.00
Taiwan Liposome (TLC) Taiwan $0.305B 0.00
MEI Pharma (MEIP) United States $0.303B 0.00
PROFOUND MEDICL (PROF) Canada $0.298B 0.00
DURECT (DRRX) United States $0.298B 0.00
TherapeuticsMD (TXMD) United States $0.295B 0.00
Nature's Sunshine Products (NATR) United States $0.289B 12.19
ALLERGY THERAPT (AGYTF) United Kingdom $0.287B 0.00
Harpoon Therapeutics (HARP) United States $0.286B 0.00
CTI BioPharma (CTIC) United States $0.285B 0.00
Avalo Therapeutics (AVTX) United States $0.280B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.280B 0.00
Sierra Oncology (SRRA) United States $0.261B 0.00
Alpine Immune Sciences (ALPN) United States $0.239B 0.00
Redhill Biopharma (RDHL) Israel $0.228B 0.00
Clever Leaves Holdings (CLVR) United States $0.226B 0.00
Adherex Technologies (FENC) United States $0.220B 0.00
Oncternal Therapeutics (ONCT) United States $0.209B 0.00
Sigilon Therapeutics (SGTX) $0.196B 0.00
CASI Pharmaceuticals (CASI) United States $0.196B 0.00
Xeris Pharmaceuticals (XERS) United States $0.173B 0.00
Calithera Biosciences (CALA) United States $0.168B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.164B 0.00
Aquestive Therapeutics (AQST) United States $0.162B 0.00
Heat Biologics (HTBX) United States $0.162B 0.00
Novan (NOVN) United States $0.161B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.159B 0.00
Savara (SVRA) United States $0.158B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.153B 0.00
OptiNose (OPTN) United States $0.152B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.147B 0.00
IMV INC (IMV) Canada $0.143B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.142B 0.00
SCYNEXIS (SCYX) United States $0.141B 0.00
Qilian Holding Group (QLI) China $0.140B 0.00
Champions Oncology (CSBR) United States $0.139B 0.00
Ardelyx (ARDX) United States $0.135B 0.00
Lannett Co Inc (LCI) United States $0.130B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
4D Pharma (LBPS) United Kingdom $0.122B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.122B 0.00
Concert Pharmaceuticals (CNCE) United States $0.119B 0.00
GlycoMimetics (GLYC) United States $0.116B 0.00
Iterum Therapeutics (ITRM) Ireland $0.114B 0.00
Jaguar Animal Health (JAGX) United States $0.112B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.111B 0.00
Vivos Therapeutics (VVOS) $0.107B 0.00
Genocea Biosciences (GNCA) United States $0.105B 0.00
Recro Pharma (REPH) United States $0.104B 0.00
Lipocine (LPCN) United States $0.102B 0.00
Otonomy (OTIC) United States $0.099B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.098B 0.00
MediWound (MDWD) Israel $0.097B 0.00
Natural Alternatives (NAII) United States $0.096B 10.01
SHINECO INC (TYHT) China $0.095B 0.00
Gain Therapeutics (GANX) United States $0.094B 0.00
Aptorum Group (APM) United Kingdom $0.090B 0.00
Ainos (AIMD) United States $0.085B 0.00
Aziyo Biologics (AZYO) United States $0.084B 0.00
XPHYTO Therapeutics (XPHYF) Canada $0.083B 0.00
HANCOCK JAFFE (HJLI) United States $0.082B 0.00
VYNE Therapeutics (VYNE) United States $0.081B 0.00
Onconova Therapeutics (ONTX) United States $0.081B 0.00
Progenity (PROG) United States $0.080B 0.00
ProPhase Labs (PRPH) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.077B 0.00
Addex Therapeutics (ADXN) Switzerland $0.076B 0.00
Minerva Neurosciences (NERV) United States $0.073B 0.00
Regulus Therapeutics (RGLS) United States $0.069B 0.00
ElectroCore (ECOR) United States $0.067B 0.00
Brickell Biotech (BBI) United States $0.064B 0.00
PolarityTE (PTE) United States $0.063B 0.00
Mannatech (MTEX) United States $0.062B 10.52
Biomerica (BMRA) United States $0.058B 0.00
Nutriband (NTRB) United States $0.057B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.055B 0.00
Inhibikase Therapeutics (IKT) United States $0.051B 0.00
Baudax Bio (BXRX) United States $0.051B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.042B 70.00
Assertio Holdings (ASRT) United States $0.041B 0.00
Phio Pharmaceuticals (PHIO) United States $0.031B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
Plus Therapeutics (PSTV) United States $0.024B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Xenetic Biosciences (XBIO) United States $0.023B 0.00
Petros Pharmaceuticals (PTPI) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.017B 13.57
China SXT Pharmaceuticals (SXTC) China $0.016B 0.00
JanOne (JAN) United States $0.015B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00